#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
17	12247302	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.3725;groupNumber5
17	12247581	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.4;groupNumber5
17	12247607	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.3788;groupNumber5
17	12247750	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.3708;groupNumber5
17	12247768	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.3882;groupNumber5
17	12247978	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.3925;groupNumber5
17	12248104	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2927;groupNumber5
17	12248170	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.3636;groupNumber5
17	13380388	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.186;groupNumber6
17	13380422	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.2222;groupNumber6
17	13380433	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.2468;groupNumber6
17	13380625	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.1667;groupNumber6
11	62249915	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4545;groupNumber11
11	62250006	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.5283;groupNumber11
11	62250051	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.5;groupNumber11
11	62250323	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.4932;groupNumber11
11	63237106	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.283;groupNumber12
11	63237294	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.2545;groupNumber12
11	63237390	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1915;groupNumber12
11	63237392	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1778;groupNumber12
11	67458180	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.3953;groupNumber14
11	67458198	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.3913;groupNumber14
11	67458261	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.3333;groupNumber14
11	67458284	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.3846;groupNumber14
11	67458333	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.3134;groupNumber14
11	90275937	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.2353;groupNumber16
11	90275948	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.2708;groupNumber16
11	90276004	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.2791;groupNumber16
11	90276131	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.2941;groupNumber16
11	96614073	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.3774;groupNumber17
11	96614145	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.3363;groupNumber17
11	96614156	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.354;groupNumber17
11	96614376	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4511;groupNumber17
11	96614524	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.4955;groupNumber17
X	16603461	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.2821;groupNumber47
X	16603493	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.3026;groupNumber47
X	16603885	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.2903;groupNumber47
X	16603954	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.2714;groupNumber47
X	16604434	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.3133;groupNumber47
X	16604571	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2188;groupNumber47
X	16605885	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2941;groupNumber47
X	16605886	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.3019;groupNumber47
X	16606257	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2791;groupNumber47
X	16606431	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.3125;groupNumber47
X	16606630	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2727;groupNumber47
X	102566027	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2222;groupNumber53
X	102566074	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1429;groupNumber53
X	102566077	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1429;groupNumber53
X	102566078	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1429;groupNumber53
6	279142	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1279;groupNumber75
6	279250	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1159;groupNumber75
6	279366	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.0867;groupNumber75
6	279403	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.013158;groupNumber75
6	279409	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.0245;groupNumber75
6	279434	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.0437;groupNumber75
6	279531	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1302;groupNumber75
6	279725	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1779;groupNumber75
6	279959	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.225;groupNumber75
6	279987	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.184;groupNumber75
6	280073	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1687;groupNumber75
6	280333	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1518;groupNumber75
6	280426	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.0735;groupNumber75
6	280439	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.0576;groupNumber75
6	280457	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.0486;groupNumber75
6	280540	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1342;groupNumber75
6	280654	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1602;groupNumber75
6	280797	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1429;groupNumber75
6	281029	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.125;groupNumber75
6	281390	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2143;groupNumber75
6	281511	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1586;groupNumber75
6	281902	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1418;groupNumber75
6	288766	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1429;groupNumber75
6	288787	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1461;groupNumber75
6	288866	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.142;groupNumber75
6	288925	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1544;groupNumber75
6	290910	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1667;groupNumber75
6	290993	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.141;groupNumber75
6	291370	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.0993;groupNumber75
6	291414	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1438;groupNumber75
6	291492	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1831;groupNumber75
6	291580	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1679;groupNumber75
6	291624	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1765;groupNumber75
6	291857	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1884;groupNumber75
6	294061	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1656;groupNumber75
6	294158	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1699;groupNumber75
6	294421	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.135;groupNumber75
6	294731	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1157;groupNumber75
6	304461	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1264;groupNumber75
6	304607	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1293;groupNumber75
6	304997	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1655;groupNumber75
6	305053	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1507;groupNumber75
6	305131	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1883;groupNumber75
6	307504	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2041;groupNumber75
6	307962	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2081;groupNumber75
6	308315	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1328;groupNumber75
6	308486	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1014;groupNumber75
6	15872294	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1753;groupNumber78
6	15872571	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2062;groupNumber78
6	15873825	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1736;groupNumber78
6	15874331	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1449;groupNumber78
6	15874410	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1556;groupNumber78
6	15874547	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1761;groupNumber78
6	15874736	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1859;groupNumber78
6	15874807	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2303;groupNumber78
6	64956271	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.0385;groupNumber83
6	64956272	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.0392;groupNumber83
6	64956295	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.069;groupNumber83
6	64956308	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.0968;groupNumber83
1	115552046	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.017559;groupNumber93
1	115552049	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.013311;groupNumber93
1	115552139	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.0381;groupNumber93
1	115552149	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.0382;groupNumber93
1	115552363	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.0502;groupNumber93
1	115552442	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.0577;groupNumber93
1	120425828	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.0508;groupNumber97
1	120425890	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.0243;groupNumber97
1	120425906	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.013333;groupNumber97
1	120426287	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.0305;groupNumber97
7	66611691	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1333;groupNumber117
7	66611744	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.1075;groupNumber117
7	66611805	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.1039;groupNumber117
7	66611978	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.1649;groupNumber117
7	66612371	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1304;groupNumber117
7	66612396	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.1373;groupNumber117
7	72890577	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.1711;groupNumber119
7	72891018	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.125;groupNumber119
7	72891146	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.202;groupNumber119
7	72891559	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.1094;groupNumber119
7	72891633	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1642;groupNumber119
